| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2010-02-16 | 2009-12-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 59,446 | Added More | 53,238 | 857.57 % | $1,911,189 | $2,139,462 | $228,273 | 11.94 % | $204,434 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 6,208 | Sold Some | -277,066 | -97.80 % | $182,453 | $223,426 | $40,973 | 22.45 % | $-1,828,636 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 283,274 | Added More | 112,246 | 65.63 % | $6,503,971 | $10,195,031 | $3,691,060 | 56.75 % | $1,462,565 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2009-06-05 | 2009-03-31 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 171,028 | Added More | 65,813 | 62.55 % | $4,402,261 | $6,155,298 | $1,753,037 | 39.82 % | $674,583 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2009-02-17 | 2008-12-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 105,215 | Added More | 104,388 | 12622.49 % | - | $3,786,688 | - | - % | | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2008-11-13 | 2008-09-30 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 827 | Sold Some | -24,913 | -96.78 % | $4,027 | $29,764 | $25,736 | 639.01 % | $-775,293 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2008-08-21 | 2008-06-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 25,740 | New Holding | 25,740 | 100 % | $149,292 | $926,383 | $777,091 | 520.51 % | $777,091 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2008-05-14 | 2008-03-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 0 | Sold All | -1,500 | -100 % | - | - | - | 555.55 % | $-45,750 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2008-02-13 | 2007-12-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 1,500 | Sold Some | -795,323 | -99.81 % | $8,520 | $53,985 | $45,465 | 533.62 % | $-24,106,240 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2007-12-26 | 2007-09-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 796,823 | Sold Some | -294,105 | -26.95 % | $5,163,413 | $28,677,660 | $23,514,247 | 455.40 % | $-8,679,039 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2007-08-30 | 2007-06-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 1,090,928 | New Holding | 1,090,928 | 100 % | $8,672,878 | $39,262,499 | $30,589,621 | 352.70 % | $30,589,621 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2007-05-16 | 2007-03-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 0 | Sold All | -321 | -100 % | - | - | - | 500.83 % | $-9,630 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2007-03-08 | 2006-12-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 321 | New Holding | 321 | 100 % | $1,278 | $11,553 | $10,275 | 804.27 % | $10,275 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2005-11-23 | 2005-09-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 0 | Sold All | -350 | -100 % | - | - | - | 482.36 % | $-10,434 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2005-11-23 | 2005-06-30 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 350 | New Holding | 350 | 100 % | $2,163 | $12,597 | $10,434 | 482.36 % | $10,434 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2005-06-29 | 2005-03-31 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 0 | Sold All | -350 | -100 % | - | - | - | 597.48 % | $-10,791 | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
| 2005-06-29 | 2004-12-31 | 13F-HR/A | Dendreon Corp | DNDN | US | Therapeutics | 350 | No Compare | - | - % | $1,806 | $12,597 | $10,791 | 597.48 % | | | | | | | History of Amvescap Plc Ownership Of Dendreon Corp |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |